Shield Therapeutics plc

Shield Therapeutics plc

Pharmaceutical Manufacturing Centre, United Kingdom 70 employees
Employees
70
Contacts
3
Emails
3
Phones
2

Shield Therapeutics plc Overview

Headquarters
Centre, United Kingdom
Industry
Pharmaceutical Manufacturing
Employees
70
Founded
2008
Funding
6.1M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Shield Therapeutics plc

Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol). The Group has launched Accrufer® in the US and Feraccru® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of Accrufer® / Feraccru® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. in the Republic of Korea, and with KYE Pharmaceuticals Inc. in Canada.

Shield Therapeutics plc Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Shield Therapeutics plc Org Chart

Sample employees and titles
Name Title Contact
Andy Hurley Board Director / Chief Operating Officer - Chief Commercial Officer - Corporate Advisor - Executive Biotech Leader
Email Phone
Anders Lundstrom Commercial Executive, Board Member, Consultant, Advisor, and Mentor
Email Phone
Rhett Ephgrave
Email
Rachel Burn QA Manager at Shield Therapeutics Plc
View

Employees by Management Level

Individual contributor 11 profiles
Manager 4 profiles
Executive 3 profiles
Director 3 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
Sales 9 9 4
General 4 4 3
Executive 1 1 0
HR 1 1 0

Compare Similar Companies to Shield Therapeutics plc